These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 8893454)
1. An examination of tissue chimerism in the ACI to Lewis rat cardiac transplant model. Frede SE; Levy AE; Alexander JW; Babcock GF Transpl Immunol; 1996 Sep; 4(3):227-31. PubMed ID: 8893454 [TBL] [Abstract][Full Text] [Related]
2. Effect of ultraviolet-B-irradiated donor-specific blood transfusions and peritransplant immunosuppression with cyclosporine on rat cardiac allograft survival. Oluwole SF; Lau HT; Reemtsma K; Hardy MA Transplantation; 1988 Feb; 45(2):293-7. PubMed ID: 3278417 [TBL] [Abstract][Full Text] [Related]
3. Prolactin suppression enhances the effects of perioperative donor-specific blood transfusions on graft survival. Martinelli GP; Liu H; Clarke WP; Heisenleder DJ; Knight RJ J Surg Res; 1996 Aug; 64(2):190-7. PubMed ID: 8812632 [TBL] [Abstract][Full Text] [Related]
4. Nutritional immunomodulation enhances cardiac allograft survival in rats treated with donor-specific transfusion and cyclosporine. Levy AE; Alexander JW Transplantation; 1995 Oct; 60(8):812-5. PubMed ID: 7482740 [TBL] [Abstract][Full Text] [Related]
5. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts. Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899 [TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory Effects of Different Cellular Therapies of Bone Marrow Origin on Chimerism Induction and Maintenance Across MHC Barriers in a Face Allotransplantation Model. Hivelin M; Klimczak A; Cwykiel J; Sonmez E; Nasir S; Gatherwright J; Siemionow M Arch Immunol Ther Exp (Warsz); 2016 Aug; 64(4):299-310. PubMed ID: 26708158 [TBL] [Abstract][Full Text] [Related]
7. Pretransplant injection of allograft recipients with donor blood or lymphocytes permits allograft tolerance without the presence of persistent donor microchimerism. Shirwan H; Wang HK; Barwari L; Makowka L; Cramer DV Transplantation; 1996 May; 61(9):1382-6. PubMed ID: 8629301 [TBL] [Abstract][Full Text] [Related]
8. A strategy for generating consistent long-term donor-specific tolerance to solid organ allografts. Levy AE; Alexander JW; Babcock GF Transpl Immunol; 1997 Jun; 5(2):83-8. PubMed ID: 9269029 [TBL] [Abstract][Full Text] [Related]
9. Detection of chimerism following vascularized bone allotransplantation by polymerase chain reaction using a Y-chromosome specific primer. Muramatsu K; Valenzuela RG; Bishop AT J Orthop Res; 2003 Nov; 21(6):1056-62. PubMed ID: 14554219 [TBL] [Abstract][Full Text] [Related]
10. The effect of nutritional immunomodulation on cardiac allograft survival in rats receiving mycophenolate mofetil, cyclosporine A, and donor-specific transfusion. Gibson SW; Valente JF; Alexander JW; Custer DA; Babcock GF; Ogle CK J Heart Lung Transplant; 1999 Mar; 18(3):185-9. PubMed ID: 10328142 [TBL] [Abstract][Full Text] [Related]
12. Prolongation of allograft survival with viral IL-10 transfection in a highly histoincompatible model of rat heart allograft rejection. Zuo Z; Wang C; Carpenter D; Okada Y; Nicolaidou E; Toyoda M; Trento A; Jordan SC Transplantation; 2001 Mar; 71(5):686-91. PubMed ID: 11292303 [TBL] [Abstract][Full Text] [Related]
13. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier. Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371 [TBL] [Abstract][Full Text] [Related]
14. Cyclosporine facilitates chimeric and inhibits nonchimeric tolerance after posttransplant total lymphoid irradiation. Lan F; Hayamizu K; Strober S Transplantation; 2000 Feb; 69(4):649-55. PubMed ID: 10708124 [TBL] [Abstract][Full Text] [Related]
15. The significance of timing of additional short-term immunosuppression in the donor-specific transfusion/cyclosporine-treated rat. Levy AE; Alexander JW Transplantation; 1996 Jul; 62(2):262-6. PubMed ID: 8755826 [TBL] [Abstract][Full Text] [Related]
16. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat. Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394 [TBL] [Abstract][Full Text] [Related]
17. Indefinite allograft survival induced by the combination of multiple donor-specific transfusions, cyclosporine, and an anti-T cell monoclonal antibody in a protocol relevant to cadaveric organ transplantation. The importance of prolonged posttransplant cyclosporine coverage. Tchervenkov JI; Cofer BR; Davies C; Alexander JW Transplantation; 1995 Mar; 59(6):821-4. PubMed ID: 7701575 [TBL] [Abstract][Full Text] [Related]
18. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade. Foster RD; Pham S; Li S; Aitouche A Transplantation; 2003 Sep; 76(6):988-94. PubMed ID: 14508367 [TBL] [Abstract][Full Text] [Related]